Effects of Lemborexant on Insomnia and Its Relationship to Mood and Behavior on Opioid Use Disorder Subjects
Phase 2
100
about 4.2 years
18+
1 site in VA
What this study is about
This trial is testing a treatment called lemborexant for insomnia in people with opioid use disorder. The goal is to see how this medication affects sleep, mood, and behavior. Researchers will compare lemborexant to a placebo (sugar pill) over 8 weeks to measure improvements on these factors.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Lemborexant 10 MG
- 2.Take Placebo
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
lemborexant
oral (Oral Tablet)
Secondary: Negative Emotionality: General Anxiety Disorder (GAD-7), Negative Emotionality: Patient Health Questionnaire (PHQ-9)
Psychiatry / Mental Health